99 related articles for article (PubMed ID: 29787570)
1. Adjuvant chemotherapy-Radiotherapy-Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases.
Schliemann C; Kerkhoff A; Hesse P; Bröckling S; Hardes J; Streitbürger A; Andreou D; Gosheger G; Elges S; Wardelmann E; Hartmann W; Mesters R; Lenz G; Willich N; Kriz J; Eich H; Berdel WE; Kessler T
PLoS One; 2018; 13(5):e0197315. PubMed ID: 29787570
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy for resectable high-risk soft tissue sarcoma: feasibility and efficacy of a sandwich chemoradiotherapy strategy.
Brandts CH; Schulz C; Willich N; Steffen B; Hardes J; Gosheger G; Winkelmann W; Serve H; Heinecke A; Berdel WE; Thomas M
Cancer Chemother Pharmacol; 2012 Mar; 69(3):613-20. PubMed ID: 21947168
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up of patients treated with neoadjuvant chemotherapy and radiotherapy for large, extremity soft tissue sarcomas.
Mullen JT; Kobayashi W; Wang JJ; Harmon DC; Choy E; Hornicek FJ; Rosenberg AE; Chen YL; Spiro IJ; DeLaney TF
Cancer; 2012 Aug; 118(15):3758-65. PubMed ID: 22180344
[TBL] [Abstract][Full Text] [Related]
4. Current trials and new aspects in soft tissue sarcoma of adults.
Issels RD; Schlemmer M
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982
[TBL] [Abstract][Full Text] [Related]
5. The risk of postoperative complications and functional impairment after multimodality treatment for limb and trunk wall soft-tissue sarcoma: Long term results from a monocentric series.
Stoeckle E; Michot A; Rigal L; Babre F; Sargos P; Henriques de Figueiredo B; Brouste V; Italiano A; Toulmonde M; Le Loarer F; Kind M
Eur J Surg Oncol; 2017 Jun; 43(6):1117-1125. PubMed ID: 28202211
[TBL] [Abstract][Full Text] [Related]
6. Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcoma of extremities and trunk wall.
Jebsen NL; Bruland ØS; Eriksson M; Engellau J; Turesson I; Folin A; Trovik CS; Hall KS
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1359-66. PubMed ID: 20933339
[TBL] [Abstract][Full Text] [Related]
7. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
[TBL] [Abstract][Full Text] [Related]
8. Perioperative chemotherapy with ifosfamide and doxorubicin for high-grade soft tissue sarcomas in the extremities (JCOG0304).
Tanaka K; Mizusawa J; Fukuda H; Araki N; Chuman H; Takahashi M; Ozaki T; Hiruma T; Tsuchiya H; Morioka H; Hatano H; Iwamoto Y
Jpn J Clin Oncol; 2015 Jun; 45(6):555-61. PubMed ID: 25838293
[TBL] [Abstract][Full Text] [Related]
9. Long-term Follow-up and Post-relapse Outcome of Patients with Localized Retroperitoneal Sarcoma Treated in the Italian Sarcoma Group-Soft Tissue Sarcoma (ISG-STS) Protocol 0303.
De Sanctis R; Giordano L; Colombo C; De Paoli A; Navarria P; Sangalli C; Buonadonna A; Sanfilippo R; Bertola G; Fiore M; Marrari A; Navarria F; Bertuzzi A; Casali PG; Basso S; Santoro A; Quagliuolo V; Gronchi A
Ann Surg Oncol; 2017 Dec; 24(13):3872-3879. PubMed ID: 29043525
[TBL] [Abstract][Full Text] [Related]
10. A phase I/II study of sequential, dose-escalated, high dose ifosfamide plus doxorubicin with peripheral blood stem cell support for the treatment of patients with advanced soft tissue sarcomas.
Bokemeyer C; Franzke A; Hartmann JT; Schöber C; Arseniev L; Metzner B; Link H; Kanz L; Schmoll HJ
Cancer; 1997 Oct; 80(7):1221-7. PubMed ID: 9317171
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
12. Impact of residual disease after "unplanned excision" of primary localized adult soft tissue sarcoma of the extremities: evaluation of 452 cases at a single Institution.
Bianchi G; Sambri A; Cammelli S; Galuppi A; Cortesi A; Righi A; Caldari E; Ferrari S; Donati D
Musculoskelet Surg; 2017 Dec; 101(3):243-248. PubMed ID: 28444540
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Perioperative Chemotherapy Timing in Conjunction With Postoperative External-Beam Radiation Therapy on Extremity Soft-Tissue Sarcomas Outcome.
Mahmoud O; Dosch A; Kwon D; Pitcher JD; Conway S; Benedetto P; Fernandez G; Trent J; Temple HT; Wolfson AH
Am J Clin Oncol; 2016 Oct; 39(5):528-34. PubMed ID: 24879472
[TBL] [Abstract][Full Text] [Related]
14. Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas.
Wendtner CM; Abdel-Rahman S; Krych M; Baumert J; Lindner LH; Baur A; Hiddemann W; Issels RD
J Clin Oncol; 2002 Jul; 20(14):3156-64. PubMed ID: 12118030
[TBL] [Abstract][Full Text] [Related]
15. Safety of concurrent adjuvant radiotherapy and chemotherapy for locally advanced soft tissue sarcoma.
Greto D; Loi M; Saieva C; Muntoni C; Delli Paoli C; Becherini C; Ciabatti C; Perna M; Campanacci D; Terziani F; Beltrami G; Scoccianti G; Bonomo P; Meattini I; Desideri I; Simontacchi G; Mangoni M; Livi L
Tumori; 2018 Oct; 104(5):322-329. PubMed ID: 29714662
[TBL] [Abstract][Full Text] [Related]
16. Preoperative chemo-radiation therapy for localised retroperitoneal sarcoma: a phase I-II study from the Italian Sarcoma Group.
Gronchi A; De Paoli A; Dani C; Merlo DF; Quagliuolo V; Grignani G; Bertola G; Navarria P; Sangalli C; Buonadonna A; De Sanctis R; Sanfilippo R; Dei Tos AP; Stacchiotti S; Giorello L; Fiore M; Bruzzi P; Casali PG
Eur J Cancer; 2014 Mar; 50(4):784-92. PubMed ID: 24316063
[TBL] [Abstract][Full Text] [Related]
17. Intensified adjuvant IFADIC chemotherapy in combination with radiotherapy versus radiotherapy alone for soft tissue sarcoma: long-term follow-up of a prospective randomized feasibility trial.
Fakhrai N; Ebm C; Kostler WJ; Jantsch M; Abdolvahab F; Dominkus M; Pokrajac B; Kauer-Dorner D; Zielinski CC; Brodowicz T;
Wien Klin Wochenschr; 2010 Nov; 122(21-22):614-9. PubMed ID: 20963638
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.
Kasper B; Ouali M; van Glabbeke M; Blay JY; Bramwell VH; Woll PJ; Hohenberger P; Schöffski P
Eur J Cancer; 2013 Jan; 49(2):449-56. PubMed ID: 22975215
[TBL] [Abstract][Full Text] [Related]
19. A retrospective cohort study to assess adjuvant concurrent chemoradiation (CCRT) compared to adjuvant radiation therapy (RT) in the treatment of grade 2 and 3 extremity soft tissue sarcomas.
Nesseler JP; Salleron J; Rios M; Nickers P; Marchal F; Brocard F; Peiffert D; Vogin G
Radiother Oncol; 2017 Oct; 125(1):160-167. PubMed ID: 28951009
[TBL] [Abstract][Full Text] [Related]
20. Effective local control of advanced soft tissue sarcoma with neoadjuvant chemoradiotherapy and surgery: A single institutional experience.
Stubbe F; Agaimy A; Ott O; Lettmaier S; Vassos N; Croner R; Hohenberger W; Fietkau R; Semrau S
Cancer Radiother; 2016 Feb; 20(1):6-13. PubMed ID: 26700874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
